Skip to content

Study · Not a test of the peptide alone · 2025

1 result

Efficacy of antiobesity medications for weight reduction in older adults: a systematic review.

Chen AS, Hajduk AM, Grimshaw AA, Fried TR, Jastreboff AM, Lipska KJ

Obesity (Silver Spring, Md.)26 Dec 2024Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Semaglutide.

  1. 01HumanNot a test of Semaglutide aloneSystematic reviewEfficacy outcome

    In a systematic review of older adults with obesity, all included studies of seven antiobesity medications (semaglutide among them) found statistically significant weight reduction versus placebo or baseline.

    In plain wordsIn older adults with obesity, all studies of seven weight-loss medications together found weight loss compared with placebo or starting weight.

    Outcome
    DecreaseWeight reduction versus placebo or baseline
    Study

    n: not reported in source

    Comparator
    Placebo or baseline weight
    Outcome group
    Body weight · Metabolic and weight

    Source sentences

    Summary
    All studies found statistically significant weight reduction between intervention and placebo groups or compared with baseline weight.
    1 context sentence
    Summary · context
    Six experimental studies (five secondary analyses of randomized clinical trial data and one single-arm trial) and two observational studies met inclusion criteria.

    In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.